Discover
ESLA
Estrella Immunopharma, Inc.
0.80
1 x 0.81
1 x 0.85
bid
ask
-
0.02
3.02%
04:00 PM
| Ytd | -48.72% | |
| 1y | -4.76% |
0.78
day range
0.83
0.73
52 week range
3.15
| Open | 0.80 | Prev Close | 0.82 | Low | 0.78 | High | 0.83 | Mkt Cap | 34.43M |
| Vol | 26.78K | Avg Vol | 42.95K | EPS | -0.35 | P/E | -2.31 | Forward P/E | N/A |
| Beta | 0.85 | Short Ratio | 0.07 | Inst. Own | 0.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.03 | 200-d Avg | 1.42 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.29M | ||
| Research and Development Expense | 1.40M | ||
| Selling, General and Administrative Expense | 891.79K | ||
| Operating Income | -2.29M | ||
| Net Income | -2.29M | ||
| Net Income Common Stock | -2.29M | ||
| Net Income Common Stock (USD) | -2.29M | ||
| Consolidated Income | -2.29M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -2.29M | ||
| Earning Before Interest & Taxes (USD) | -2.29M | ||
| Weighted Average Shares | 42.12M | ||
| Weighted Average Shares Diluted | 42.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.93M | ||
| Cash and Equivalents (USD) | 1.93M | ||
| Current Assets | 2.16M | ||
| Total Assets | 3.66M | ||
| Current Liabilities | 8.93M | ||
| Total Liabilities | 8.93M | ||
| Accumulated Retained Earnings (Deficit) | -39.28M | ||
| Shareholders Equity | -5.27M | ||
| Shareholders Equity (USD) | -5.27M | ||
| Assets Non-Current | 1.50M | ||
| Trade and Non-Trade Payables | 14.95K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 7.24M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 543.10K | ||
| Issuance (Purchase) of Equity Shares | 8.00M | ||
| Net Cash Flow from Operations | -6.70M | ||
| Share Based Compensation | 146.71K | ||